Introduction：Basic information about CAS 571-20-0|5α-Androstane-3β,17β-diol, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 5α-Androstane-3β,17β-diol |
|---|
| CAS Number | 571-20-0 | Molecular Weight | 292.456 |
|---|
| Density | 1.1±0.1 g/cm3 | Boiling Point | 415.0±18.0 °C at 760 mmHg |
|---|
| Molecular Formula | C19H32O2 | Melting Point | 121-128 °C(lit.) |
|---|
| MSDS | / | Flash Point | 186.0±15.8 °C |
|---|
Names
| Name | 5α-androstane-3β,17β-diol |
|---|
| Synonym | More Synonyms |
|---|
Chemical & Physical Properties
| Density | 1.1±0.1 g/cm3 |
|---|
| Boiling Point | 415.0±18.0 °C at 760 mmHg |
|---|
| Melting Point | 121-128 °C(lit.) |
|---|
| Molecular Formula | C19H32O2 |
|---|
| Molecular Weight | 292.456 |
|---|
| Flash Point | 186.0±15.8 °C |
|---|
| Exact Mass | 292.240234 |
|---|
| PSA | 40.46000 |
|---|
| LogP | 4.33 |
|---|
| Vapour Pressure | 0.0±2.2 mmHg at 25°C |
|---|
| Index of Refraction | 1.546 |
|---|
| InChIKey | CBMYJHIOYJEBSB-YSZCXEEOSA-N |
|---|
| SMILES | CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O |
|---|
Toxicological Information
CHEMICAL IDENTIFICATION - RTECS NUMBER :
- BV8044320
- CHEMICAL NAME :
- 5-alpha-Androstane-3-beta,17-beta-diol
- CAS REGISTRY NUMBER :
- 571-20-0
- BEILSTEIN REFERENCE NO. :
- 2559488
- LAST UPDATED :
- 199709
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C19-H32-O2
- MOLECULAR WEIGHT :
- 292.51
HEALTH HAZARD DATAACUTE TOXICITY DATA - TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Subcutaneous
- DOSE :
- 48 mg/kg
- SEX/DURATION :
- male 6 day(s) pre-mating
- TOXIC EFFECTS :
- Reproductive - Paternal Effects - prostate, seminal vesicle, Cowper's gland, accessory glands
- REFERENCE :
- JSTBBK Journal of Steroid Biochemistry. (Pergamon Press Ltd., Headington Hill Hall, Oxford OX3 0BW, UK) V.1- 1969- Volume(issue)/page/year: 18,397,1983
- TYPE OF TEST :
- TDLo - Lowest published toxic dose
- ROUTE OF EXPOSURE :
- Intramuscular
- DOSE :
- 8 mg/kg
- SEX/DURATION :
- female 13-20 day(s) after conception
- TOXIC EFFECTS :
- Reproductive - Specific Developmental Abnormalities - urogenital system
- REFERENCE :
- ENDOAO Endocrinology (Baltimore). (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21203) V.1- 1917- Volume(issue)/page/year: 99,1490,1976
|
Safety Information
| Hazard Codes | Xi |
|---|
| Risk Phrases | 36/38 |
|---|
| Safety Phrases | S24-S45 |
|---|
| RTECS | BV8044320 |
|---|
Synonyms
| Androstane-3,17-diol |
| 3b,17b-Dihydroxy-5a-androstane |
| MFCD00064140 |
| (3β,5α,17β)-Androstane-3,17-diol |
| 3β-Androstanediol |
| 3β androstanediol |
| 5α-Androstane-3β,17β-diol |
| EINECS 209-334-3 |
| 5A-Androstan-3B,17B-diol |
| 5α-Androstane-3β,17β-diol (8CI) |
| (3S,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol |
| Androstane-3,17-diol, (3β,5α,17β)- |
| 5alpha-androstane-3beta,17beta-diol |
| 5a-Androstane-3b,17b-diol |
